Increasing evidence is bringing out the need to anticipate TKI treatment in first-line over chemotherapy [5] but, in the literature, data about TKI after TKI failure or comparison between two TKIs for RET-rearranged NSCLC are still lacking. Here, RET is linked to non-small cell lung carcinoma.